Pancreatic Cancer Research

ResearcherTaizhou Central HospitalNo recent work listed

Kunpeng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5088-2548; OpenAlex author ID A5100676179. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing… Co-author DOI 10.1002/cam4.3627↗
  2. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment. Co-author DOI 10.2147/dddt.s323360↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fanhua Kong · 2 shared papers, 2021 · strength 0.29
  2. Xiongying Miao · 1 shared paper, 2021 · strength 0.15
  3. Yanwen Zheng · 1 shared paper, 2021 · strength 0.15
  4. Jinggang Mo · 1 shared paper, 2021 · strength 0.15
  5. Xuyang Hou · 1 shared paper, 2021 · strength 0.14
  6. Jun He · 1 shared paper, 2021 · strength 0.14
  7. Yan Zhou · 1 shared paper, 2021 · strength 0.14
  8. Leping Yang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.